Skip to content

A study to compare the effectiveness of two different doses of oral Pregabalin,given before surgery,in reducing post operative pain after abdominal surgery under spinal anesthesia

Effect of Varying Doses of Oral Pregabalin as Preemptive Analgesic in patients undergoing Infraumbilical Laprotomy under Spinal Anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/07/008978
Enrollment
44
Registered
2017-07-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Group A: Group A will receive a single administration of oral Pregabalin 75 mg,one hour prior to Spinal anesthesia Control Intervention1: Group B: Group B will receive a single administ

Sponsors

Azeezia Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex,between age 18 years-65years,ASA physical status 1-2,who are scheduled for infraumbilical laprotomy under Spinal Anesthesia and are willing and able to give informed consent will be recruited to the trial

Exclusion criteria

Exclusion criteria: Patients with 1.known drug allergy to pregabalin 2.uncontrolled hypertension 3.uncontrolled diabetes mellitus 4.ischemic heart disease 5.cerebrovascular disease 6.renal and hepatic disease 7.history of alcohol and drug abuse 8.any general contraindications for spinal anaesthesia 9.chronic pain and neurological disorders 10.on NSAIDâ??s and on other analgesics 11.Pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
24 hour total rescue analgesic (diclofenac +/-pentazocine) consumptionTimepoint: At 24 hours post operatively.

Secondary

MeasureTime frame
Reduction of postoperative pain scores,Time to first requirement of rescue analgesia, Recovery time from sensory block and Tolerability of the used doses represented by the side effects.Timepoint: at 4,8,12,16,20 and 24 hours post operatively.

Countries

India

Contacts

Public ContactDR DERLIN THOMAS

Azeezia Medical College Hospital,Kollam

derlin.t@gmail.com09447768944

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026